Group One Trading’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76K Sell
283
-670
-70% -$3.88K ﹤0.01% 7015
2026
Q2
$5.8K Buy
953
+599
+169% +$14.4K ﹤0.01% 6673
2026
Q1
$9K Buy
+354
New +$10K ﹤0.01% 6423
2025
Q4
– Sell
-100
Closed -$1.63K – 8995
2025
Q3
$1.54K Buy
+100
New +$1.43K ﹤0.01% 7973

Other funds holding RGC

Group One Trading's RGC Position: Q3 2026 in Review

Group One Trading reduced its Regencell Bioscience (RGC) stake by 70% in Q3 2026, selling an estimated $3.88K and leaving 283 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #7015.

Group One Trading first reported a position in RGC in Q3 2025 and has held it in 4 quarters since. The position peaked at $9K in Q1 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Group One Trading held 283 shares of Regencell Bioscience worth $1.76K as of Q3 2026.
  • Group One Trading sold 670 Regencell Bioscience shares in Q3 2026, an estimated $3.88K.
  • Regencell Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7015 holding.
  • Group One Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 4 quarters since.
  • Group One Trading's Regencell Bioscience position peaked at $9K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.